Acute Severe Vision Decrease Immediately After Photodynamic Therapy
نویسندگان
چکیده
منابع مشابه
Severe decrease in visual acuity with choroidal hypoperfusion after photodynamic therapy
BACKGROUND Photodynamic therapy (PDT) is considered a selective method of treatment which works in areas of choroidal neovascularization (CNV); however, there are reports of choroidal hypoperfusion after PDT. This paper presents a clinical case of choroidal circulation disturbances caused by PDT, accompanied by CNV progression. CASE REPORT The patient, a 75-year-old woman, was qualified for P...
متن کاملComplications after photodynamic therapy.
OBJECTIVE To evaluate the incidence of complications of photodynamic therapy (PDT) with verteporfin in subfoveal choroidal neovascularizations secondary to age-related macular degeneration and pathologic myopia. METHODS In this retrospective interventional case series, the occurrence of complications after PDT in a clinical setting was analyzed. Consecutive medical records of patients with ag...
متن کاملOcular changes after photodynamic therapy.
PURPOSE The aim of this study was to identify the changes in the primate visual system after a single session of photodynamic therapy (PDT) in an intact nonhuman primate retina. METHODS As part of a larger study, PDT (wavelength 689 nm, 50 J/cm2, 600 mW/cm2, 83 seconds, 4-mm spot size) with verteporfin (6 mg/m2 intravenous infusion) was performed in one eye each of two cynomolgus monkeys. Fun...
متن کاملExudative complications after photodynamic therapy.
Nile virus ranges from 3 to 14 days. Two serosurveys have shown that approximately 1 in 150 infections resulted in meningitis or encephalitis, but most human infections remain subclinical. The reported symptoms and signs associated with West Nile virus infection include fever, malaise, anorexia, nausea, vomiting, headache, myalgia, rash, and lymphadenopathy. The frequencies of various symptoms ...
متن کاملPhotodynamic therapy (PDT)
Photodynamic therapy (PDT) is a comparatively novel therapeutic method involving a safe light source and a light-sensitive substance, termed as photosensitizers (PSs), such as methylene blue (MB), toluidine blue (TBO), sulfonated aluminum phthalocyanine, chlorine derivatives, nontoxic indocyanine green (ICG), and curcumin (CUR). (1) The combination of a nontoxic PS with low-intensity visible li...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Ophthalmology
سال: 2004
ISSN: 0003-9950
DOI: 10.1001/archopht.122.10.1546